Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Østergaard

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Nucleic Acids Research|May 26, 2019
Fatty acid conjugation enhances potency of antisense oligonucleotides in muscleThazha P Prakash, Adam E Mullick, Richard G Lee, et al.
Nucleic Acids Research|August 22, 2013
Rational design of antisense oligonucleotides targeting single nucleotide polymorphisms for potent and allele selective suppression of mutant Huntingtin in the CNSMichael E Østergaard, Amber L Southwell, Holly Kordasiewicz, et al.
Bioconjugate Chemistry|May 27, 2015
Efficient Synthesis and Biological Evaluation of 5'-GalNAc Conjugated Antisense OligonucleotidesMichael E Østergaard, Jinghua Yu, Garth A Kinberger, et al.
Nucleic Acids Research|January 26, 2020
Understanding the effect of controlling phosphorothioate chirality in the DNA gap on the potency and safety of gapmer antisense oligonucleotidesMichael E Østergaard, Cheryl L De Hoyos, W Brad Wan, et al.
Human Molecular Genetics|March 6, 2015
HD iPSC-derived neural progenitors accumulate in culture and are susceptible to BDNF withdrawal due to glutamate toxicityVirginia B Mattis, Colton Tom, Sergey Akimov, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 27, 2025
Cone beam CT dose optimisation: A review and expert consensus by the 2022 ESTRO Physics Workshop IGRT working groupLydia J Wilson, Andria Hadjipanteli, Daniella E Østergaard, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 8, 2014
In vivo evaluation of candidate allele-specific mutant huntingtin gene silencing antisense oligonucleotidesAmber L Southwell, Niels H Skotte, Holly B Kordasiewicz, et al.
Plos One|September 11, 2014
Allele-specific suppression of mutant huntingtin using antisense oligonucleotides: providing a therapeutic option for all Huntington disease patientsNiels H Skotte, Amber L Southwell, Michael E Østergaard, et al.
Nucleic Acids Research|August 21, 2021
Towards next generation antisense oligonucleotides: mesylphosphoramidate modification improves therapeutic index and duration of effect of gapmer antisense oligonucleotidesBrooke A Anderson, Graeme C Freestone, Audrey Low, et al.
Journal of the American Chemical Society|February 24, 2021
Glucagon Like Peptide 1 Receptor Agonists for Targeted Delivery of Antisense Oligonucleotides to Pancreatic Beta CellLaurent Knerr, Thazha P Prakash, Richard Lee, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Nucleic Acids Research|May 26, 2019
Fatty acid conjugation enhances potency of antisense oligonucleotides in muscleThazha P Prakash, Adam E Mullick, Richard G Lee, et al.
Nucleic Acids Research|August 22, 2013
Rational design of antisense oligonucleotides targeting single nucleotide polymorphisms for potent and allele selective suppression of mutant Huntingtin in the CNSMichael E Østergaard, Amber L Southwell, Holly Kordasiewicz, et al.
Bioconjugate Chemistry|May 27, 2015
Efficient Synthesis and Biological Evaluation of 5'-GalNAc Conjugated Antisense OligonucleotidesMichael E Østergaard, Jinghua Yu, Garth A Kinberger, et al.
Nucleic Acids Research|January 26, 2020
Understanding the effect of controlling phosphorothioate chirality in the DNA gap on the potency and safety of gapmer antisense oligonucleotidesMichael E Østergaard, Cheryl L De Hoyos, W Brad Wan, et al.
Human Molecular Genetics|March 6, 2015
HD iPSC-derived neural progenitors accumulate in culture and are susceptible to BDNF withdrawal due to glutamate toxicityVirginia B Mattis, Colton Tom, Sergey Akimov, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 27, 2025
Cone beam CT dose optimisation: A review and expert consensus by the 2022 ESTRO Physics Workshop IGRT working groupLydia J Wilson, Andria Hadjipanteli, Daniella E Østergaard, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 8, 2014
In vivo evaluation of candidate allele-specific mutant huntingtin gene silencing antisense oligonucleotidesAmber L Southwell, Niels H Skotte, Holly B Kordasiewicz, et al.
Plos One|September 11, 2014
Allele-specific suppression of mutant huntingtin using antisense oligonucleotides: providing a therapeutic option for all Huntington disease patientsNiels H Skotte, Amber L Southwell, Michael E Østergaard, et al.
Nucleic Acids Research|August 21, 2021
Towards next generation antisense oligonucleotides: mesylphosphoramidate modification improves therapeutic index and duration of effect of gapmer antisense oligonucleotidesBrooke A Anderson, Graeme C Freestone, Audrey Low, et al.
Journal of the American Chemical Society|February 24, 2021
Glucagon Like Peptide 1 Receptor Agonists for Targeted Delivery of Antisense Oligonucleotides to Pancreatic Beta CellLaurent Knerr, Thazha P Prakash, Richard Lee, et al.
Pageof 6